Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60
Published July 17, 2024 · Recall initiated: June 24, 2024
Summary
FDA records drug Class III recall D-0599-2024, published July 17, 2024 and initiated June 24, 2024. Recalling firm: Rising Pharma Holding, Inc.; Status: Ongoing; Reported quantity: 868 tubes; Lot: Lot #, DI2303B, Exp 12/31/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.
What to do
Voluntary: Firm initiated · Letter
Get an email if DIFLORASONE DIACETATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIFLORASONE DIACETATE
- Manufacturer
- Rising Pharma Holding, Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot #, DI2303B, Exp 12/31/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMicafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC,July 17, 2024
- FDAFarmalac powdered infant formula with iron 12.4 oz cansJuly 17, 2024
- FDAMicafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus LifesciencesJuly 17, 2024
- FDACrecelac Infant 0-12 powdered infant formula with iron 12.4 oz cansJuly 17, 2024
- FDALidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, RxJuly 17, 2024
- FDAFarmalac 0-12 Low lactose powdered infant formula with iron 12.4 oz cansJuly 17, 2024
Questions about this recall
Was Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60 recalled?
Yes. FDA published recall D-0599-2024 on July 17, 2024. Reported hazard: Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIFLORASONE DIACETATE.